Honorees for best pharmaceutical agent and best biotechnology product to be recognized at Sept. 24 gala ceremony
NEW YORK, Aug. 12 /PRNewswire-USNewswire/ -- The Prix Galien USA 2008 (http://www.prix-galien-usa.com) will recognize innovative biopharmaceutical drugs and devices that have made a deep impact on the quality of human life in ways that range from providing treatment for cancer and HIV/AIDS to hypertension and chronic pain. Charlie Rose will again emcee the awards ceremony on September 24, 2008, to be held at the American Museum of Natural History in New York.
The final candidates for the Prix Galien USA 2008 awards are:
-- Actelion Ltd. - Ventavis(R) (Iloprost)
-- Alexion Pharmaceuticals - Soliris(TM)
-- BioMarin Pharmaceutical Inc. - Nagalzyme(R)
-- Bristol-Myers Squibb - Sprycel(R)
-- Boehringer Ingelheim - Aptivus(R) and Spiriva(R)
-- Celgene Corporation - Revlimid(R)
-- CV Therapeutics Inc. - Ranexa(R) (ranolazine)
-- Elan Corporation - Prialt(R) (ziconotide intrathecal infusion)
-- Eli Lilly Company - Evista(R) raloxifene HCI
-- Genzyme Corporation - Myozyme(R)
-- GlaxoSmithKline - Tykerb(TM) (lapatinib) and Altabax(TM) (retapamulin ointment)
-- Merck & Co. - Isentress(R) (raltegravir)
-- Novartis AG - Exjade(R) (deferasirox) and Tekturna(R)
-- Nycomed - Omnaris
-- Pfizer Inc. - Selzentry(TM)
-- Roche Laboratories Inc. - Boniva(R)
-- sanofi-aventis - Lovenox(R)
-- Sanofi Pasteur - H5N1 influenza virus vaccine
-- Sucampo Pharmaceuticals, Inc. - Amitiza(R)
-- Wyeth - Infuse/InductOs (rh BMP-2 dibotermin alfa) Torisel (temsirolimus) Injection.
"Nominees for the Prix Galien USA stand apart from other drugs in the marketplace for the amount of research and level of skill that was invested to develop these innovative medicines that improve lives," said Gerald Weissmann, M.D., Prix Galien USA committee chair, New York University professor emeritus and editor-in-chief of The FASEB Journal.
At the awards ceremony The Population Council and Sheldon Segal, distinguished scientist at the organization, will receive the Prix Galien USA 2008 Pro Bono Humanum Award along with other members of the coalition -- Wyeth, Dow Corning and the late Judah Folkman of Harvard University -- that made possible the development and distribution of implantable hormone delivery systems that are used for birth control and family planning purposes by more than 8 million women worldwide.
The Prix Galien USA Awards (http://www.prix-galien-usa.com) committee of 11, including 7 Nobel Laureates, recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines that improve the human condition, and is considered the industry's highest accolade for pharmaceutical research and development -- equivalent to the Nobel Prize.
|SOURCE Prix Galien USA|
Copyright©2008 PR Newswire.
All rights reserved